Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.
Insulet Corp. (PODD) shares rose 1.39% to $154.61 on Tuesday, despite a broader market decline, with the S&P 500 and Dow Jones falling 0.67% and 0.65%, respectively. The stock remains 56.43% below its 52-week high of $354.88. Compared to competitors, Insulet underperformed as Eli Lilly, DexCom, and Johnson & Johnson saw gains of 3.37%, 2.86%, and 0.47%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments